Association of Inflammatory Indicators and Clinical Signs and Itch in Atopic Dermatitis Patients Treated with Simiao Pill Combined with Halomethasone Cream

References

• Patruno C, Potestio L, Napolitano M. Clinical phenotypes of adult atopic dermatitis and related therapies. Curr Opin Allergy Clin Immunol. 2022;22(4):242–249. doi:10.1097/ACI.0000000000000837
   PubMed Web of Science ®Google Scholar
• Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. 2021;22(8):4130. doi:10.3390/ijms22084130
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang F, Li X, et al. Integrated multi-omics techniques and network pharmacology analysis to explore the material basis and mechanism of Simiao pill in the treatment of rheumatoid arthritis. ACS Omega. 2023;8(12):11138–11150. doi:10.1021/acsomega.2c07959
   PubMed Web of Science ®Google Scholar
• Cao J, Liu H, Ding XJ. Effect of halometasone cream combined with Simiao pill on the therapeutic effect and expression of serum leukotriene B4 (LTB4) and thymic stromal lymphopoietin (TSLP) in patients with eczema, and the factors influencing its clinical efficacy. Ann Palliat Med. 2021;10(11):11643–11652. doi:10.21037/apm-21-2685
   PubMed Web of Science ®Google Scholar
• Tian BW, Yang YF, Yang CC, et al. Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy. 2022;14(18):1481–1496. doi:10.2217/imt-2022-0133
   PubMed Web of Science ®Google Scholar
• Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666–682. doi:10.1038/s41569-021-00552-1
   PubMed Web of Science ®Google Scholar
• Krainer J, Siebenhandl S, Weinhäusel A. Systemic autoinflammatory diseases. J Autoimmun. 2020;109:102421. doi:10.1016/j.jaut.2020.102421
   PubMed Web of Science ®Google Scholar
• Annen S, Horiguchi G, Teramukai S, et al. Association of transition of laboratory markers with transition of disease activity in psoriasis patients treated with biologics. J Nippon Med Sch. 2022;89(6):587–593. doi:10.1272/jnms.JNMS.2022_89-613
   PubMed Web of Science ®Google Scholar
• Hagino T, Saeki H, Kanda N. Biomarkers and predictive factors for treatment response to tumor necrosis factor-α inhibitors in patients with psoriasis. J Clin Med. 2023;12(3):974. doi:10.3390/jcm12030974
   PubMed Web of Science ®Google Scholar
• Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol. 2001;145(5):720–729. doi:10.1046/j.1365-2133.2001.04456.x
   PubMed Web of Science ®Google Scholar
• Inokuchi-Sakata S, Ishiuji Y, Katsuta M, et al. Role of eosinophil relative count and neutrophil-to-lymphocyte ratio in the assessment of severity of atopic dermatitis. Acta Derm Venereol. 2021;101(7):adv00491. doi:10.2340/00015555-3838
   PubMedGoogle Scholar
• Hagino T, Saeki H, Fujimoto E, Kanda N. The eosinophil-to-lymphocyte ratio acts as an indicator for improvement of clinical signs and itch by upadacitinib treatment in atopic dermatitis. J Clin Med. 2023;12(6):2201. doi:10.3390/jcm12062201
   PubMed Web of Science ®Google Scholar
• Liu M, Yokomizo T. The role of leukotrienes in allergic diseases. Allergol Int. 2015;64(1):17–26. doi:10.1016/j.alit.2014.09.001
   PubMed Web of Science ®Google Scholar
• Nitta T, Suzuki H. Thymic stromal cell subsets for T cell development. Cell Mol Life Sci. 2016;73(5):1021–1037. doi:10.1007/s00018-015-2107-8
   PubMed Web of Science ®Google Scholar
• Katoh N, Ohya Y, Ikeda M, et al. Japanese guidelines for atopic dermatitis 2020. Allergol Int. 2020;69(3):356–369. doi:10.1016/j.alit.2020.02.006
   PubMed Web of Science ®Google Scholar
• Chopra R, Vakharia PP, Sacotte R, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177(5):1316–1321. doi:10.1111/bjd.15641
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Reaney M, Mastey V, et al. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis. Br J Dermatol. 2019;181(4):761–769. doi:10.1111/bjd.17744
   PubMed Web of Science ®Google Scholar
• Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol. 1994;93(5):864–869. doi:10.1016/0091-6749(94)90379-4
   PubMed Web of Science ®Google Scholar
• Kühn H, Kolkhir P, Babina M, et al. Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies. J Allergy Clin Immunol. 2021;147(2):456–469. doi:10.1016/j.jaci.2020.08.027
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu S, Liu P, Mu Z, Zhang J. Clinical relevance of eosinophils, basophils, serum total IgE level, allergen-specific IgE, and clinical features in atopic dermatitis. J Clin Lab Anal. 2020;34(6):e23214. doi:10.1002/jcla.23214
   PubMed Web of Science ®Google Scholar
• Nakashima C, Ishida Y, Kitoh A, Otsuka A, Kabashima K. Interaction of peripheral nerves and mast cells, eosinophils, and basophils in the development of pruritus. Exp Dermatol. 2019;28(12):1405–1411. doi:10.1111/exd.14014
   PubMed Web of Science ®Google Scholar
• Kunsleben N, Rüdrich U, Gehring M, Novak N, Kapp A, Raap U. IL-31 induces chemotaxis, calcium mobilization, release of reactive oxygen species, and CCL26 in eosinophils, which are capable to release IL-31. J Invest Dermatol. 2015;135(7):1908–1911. doi:10.1038/jid.2015.106
   PubMed Web of Science ®Google Scholar
• Walker C, Kägi MK, Ingold P, et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy. 1993;23(2):145–153. doi:10.1111/j.1365-2222.1993.tb00310.x
   PubMed Web of Science ®Google Scholar
• Nakamura M, Shimizu T. Recent advances in function and structure of two leukotriene B4 receptors: BLT1 and BLT2. Biochem Pharmacol. 2022;203:115178. doi:10.1016/j.bcp.2022.115178
   PubMed Web of Science ®Google Scholar
• Fogh K, Herlin T, Kragballe K. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. J Allergy Clin Immunol. 1989;83(2 Pt 1):450–455. doi:10.1016/0091-6749(89)90132-2
   PubMed Web of Science ®Google Scholar
• Reilly DM, Parslew R, Sharpe GR, Powell S, Green MR. Inflammatory mediators in normal, sensitive and diseased skin types. Acta Derm Venereol. 2000;80(3):171–174. doi:10.1080/000155500750042907
   PubMed Web of Science ®Google Scholar
• Ruzicka T, Simmet T, Peskar BA, Ring J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol. 1986;86(2):105–108. doi:10.1111/1523-1747.ep12284061
   PubMed Web of Science ®Google Scholar
• Simon D, Hoesli S, Roth N, Staedler S, Yousefi S, Simon HU. Eosinophil extracellular DNA traps in skin diseases. J Allergy Clin Immunol. 2011;127(1):194–199. doi:10.1016/j.jaci.2010.11.002
   PubMed Web of Science ®Google Scholar
• Morshed M, Yousefi S, Stöckle C, Simon HU, Simon D. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy. 2012;67(9):1127–1137. doi:10.1111/j.1398-9995.2012.02868.x
   PubMed Web of Science ®Google Scholar
• Wang SH, Zuo YG. Thymic stromal lymphopoietin in cutaneous immune-mediated diseases. Front Immunol. 2021;12:698522. doi:10.3389/fimmu.2021.698522
   PubMed Web of Science ®Google Scholar
• Oetjen LK, Mack MR, Feng J, et al. Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch. Cell. 2017;171(1):217–228.e13. doi:10.1016/j.cell.2017.08.006
   PubMed Web of Science ®Google Scholar
• Wilson SR, Thé L, Batia LM, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285–295. doi:10.1016/j.cell.2013.08.057
   PubMed Web of Science ®Google Scholar
• Tétart F, Joly P. Eczema in elderly people. Eur J Dermatol. 2020;30(6):663–667. doi:10.1684/ejd.2020.3915
   PubMed Web of Science ®Google Scholar
• Kimura N, Nakagami G, Takehara K, et al. Prevalence of asteatosis and asteatotic eczema among elderly residents in facilities covered by long-term care insurance. J Dermatol. 2013;40(9):770–771. doi:10.1111/1346-8138.12217
   PubMed Web of Science ®Google Scholar
• Nomura T, Kabashima K. Advances in atopic dermatitis in 2019–2020: endotypes from skin barrier, ethnicity, properties of antigen, cytokine profiles, microbiome, and engagement of immune cells. J Allergy Clin Immunol. 2021;148(6):1451–1462. doi:10.1016/j.jaci.2021.10.022
   PubMed Web of Science ®Google Scholar
• Zhou L, Leonard A, Pavel AB, et al. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol. 2019;144(1):144–156. doi:10.1016/j.jaci.2019.01.015
   PubMed Web of Science ®Google Scholar
• Norlin JM, Nilsson K, Persson U, Schmitt-Egenolf M. Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals. Br J Dermatol. 2020;182(4):965–973. doi:10.1111/bjd.18361
   PubMed Web of Science ®Google Scholar